When comparing intake assessment tools across teletherapy platforms—especially for complex or overlapping diagnoses—the client should evaluate the clinical quality of the assessment process, not simply how many questionnaires a platform offers.
1. Look for validated, diagnosis-relevant instruments
A strong platform should use established screening and outcome measures rather than proprietary questionnaires with unclear psychometric evidence.
Ask:
- Are the instruments validated and reliable?
- Are they appropriate for the client's age, language, culture, and clinical population?
- Do they distinguish between conditions with overlapping symptoms?
- Does the platform support multiple measures, rather than forcing one diagnosis-oriented screen?
- Can clinicians add or select assessments based on the presenting problem?
For complex cases, a questionnaire should be viewed as one source of evidence, not as a diagnostic decision by itself. APA's current measurement-based-care guidance emphasizes using assessment data alongside clinical formulation and ongoing clinical judgment.
2. Check whether the platform supports differential assessment
This is particularly important with presentations involving, for example, mood symptoms plus trauma, substance use, ADHD/autism-related concerns, psychosis, personality features, or medical contributors.
A higher-quality system should allow the clinician to investigate:
- Presenting symptoms and severity
- Functional impairment
- Risk and safety
- Substance use
- Medical/medication factors
- Trauma history when clinically appropriate
- Relevant developmental history
- Previous diagnoses and treatment
- Co-occurring conditions
- Protective factors and social circumstances
- Collateral information when appropriate
A platform that essentially says “complete this depression questionnaire → depression diagnosis” is substantially less useful for complex presentations than one that supports a broader clinical formulation.
3. Verify that the assessments actually work remotely
This is an easy area to overlook. A test being available online does not automatically mean that its remote administration has been validated.
APA's telepsychology guidance recommends considering the evidence base, norms, reliability, validity, clinical utility, and limitations of assessments delivered remotely. It also emphasizes that some assessments translate to telehealth more readily than others.
Ask the platform:
“Which of your assessment instruments have evidence supporting equivalence between remote and in-person administration?”
That's a much more informative question than simply asking whether the platform has “digital assessments.”
4. Evaluate what happens when an assessment identifies risk
For complex cases, this may be more important than the questionnaire itself.
Determine whether a concerning response—such as suicidality, homicidality, severe substance use, psychosis, or acute deterioration—automatically triggers an appropriate clinical review and escalation process, rather than simply being stored in the patient's chart.
This matters particularly in asynchronous assessment. APA notes that remote measurement requires care so that a high-risk response does not leave a patient waiting an inappropriate length of time for clinician contact.
SAMHSA likewise describes telehealth screening and assessment as useful for serious mental illness and substance-use disorders, while distinguishing screening from the broader clinical assessment process.
5. Examine clinician access to the raw information
A good system shouldn't merely produce a label or score.
Prefer platforms where the clinician can see:
- Individual item responses when clinically appropriate
- Scores and scoring methodology
- Changes over time
- Previous assessment results
- Relevant narrative/contextual information
- Alerts requiring clinical attention
- Patient-reported and clinician-reported information separately
APA's measurement-based-care guidelines specifically emphasize routinely reviewing assessment data and incorporating it into clinical impressions, case conceptualization, and treatment planning.
6. Assess inclusivity and accommodations
For complex diagnoses, demographic and functional factors can substantially affect interpretation.
Ask whether assessments accommodate:
- Different languages
- Reading/cognitive limitations
- Disabilities
- Neurodivergent patients
- Cultural differences
- Hearing or visual limitations
- Patients with limited technological access
APA identifies cognitive, auditory, visual, mobility, language, technology-access, privacy, and other patient needs as considerations in telepsychology.
7. Use a weighted comparison rather than “number of assessments”
A practical client scorecard could look like this:
| Criterion | Weight |
|---|
| Psychometric validity/reliability | 25% |
| Coverage of comorbidity & differential assessment | 20% |
| Remote-administration evidence | 15% |
| Risk/safety workflows | 15% |
| Clinician interpretation & integration | 10% |
| Longitudinal measurement | 5% |
| Accessibility/cultural appropriateness | 5% |
| Privacy/security & data handling | 5% |
For complex diagnoses, I'd put considerably more weight on the first five categories than on convenience, interface design, or the sheer number of available questionnaires.
Bottom line
The best teletherapy intake tool isn't necessarily the platform with the most assessments. It's the one that gives a qualified clinician valid information, appropriate context, reliable remote administration, meaningful longitudinal data, and a safe mechanism for acting on concerning findings.
A particularly good due-diligence question is:
“Show me exactly how your intake assessment handles a patient with overlapping symptoms and possible comorbidities, including what the clinician sees, which validated instruments are used, how remote validity was established, and what happens when the results indicate elevated risk.”
If a platform cannot answer those questions clearly, I'd treat that as a significant quality concern.